Javelin Pharmaceuticals Inc.
Javelin Pharmaceuticals, Inc. is a specialty pharmaceutical company that applies proprietary technologies to develop new products and improved formulations of existing drugs that target current unmet and underserved medical needs primarily in the pain management market. Javelin develops simple and user-friendly products, including new modes and routes of delivery for drugs optimized for relieving moderate-to-severe pain.

Company was acquired by Hospira, Inc.